These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10808378)

  • 1. Unresectable adenocarcinoma of the pancreas.
    Klaassen DJ
    Cancer Invest; 2000; 18(4):406-7. PubMed ID: 10808378
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.
    Bekaii-Saab T; Yu K; Lima CMSR; Wolin EM
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):1-16. PubMed ID: 30807558
    [No Abstract]   [Full Text] [Related]  

  • 3. Unresectable adenocarcinoma of the pancreas: patterns of failure and treatment results.
    Paulino AC; Latona C
    Cancer Invest; 2000; 18(4):309-13. PubMed ID: 10808366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of locally advanced pancreatic carcinoma--a dual challenge.
    Kjaer M
    Radiother Oncol; 1997 Nov; 45(2):105-7. PubMed ID: 9423998
    [No Abstract]   [Full Text] [Related]  

  • 5. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.
    Carter SK; Comis RL
    Cancer Treat Rev; 1975 Sep; 2(3):193-214. PubMed ID: 1104163
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained Disease Control with TOMOXIRI Regimen in a Patient with Metastatic Pancreatic Adenocarcinoma.
    De Dosso S; Melchiorre P; Della Badia C; Moschovitis G; Saletti P
    J Gastrointest Cancer; 2015 Sep; 46(3):327-31. PubMed ID: 25832479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy for unresectable metastatic pancreas cancer].
    Ottomo S; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1648-51. PubMed ID: 19891092
    [No Abstract]   [Full Text] [Related]  

  • 8. Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Yu K
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):9-10. PubMed ID: 30807562
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiation therapy for unresectable pancreatic adenocarcinoma: population-based trends in utilization and survival rates in the United States.
    Shapiro M; Rashid NU; Huang Q; Galper SL; Boosalis VA; Whang EE; Gold JS
    JAMA Surg; 2015 Mar; 150(3):274-7. PubMed ID: 25629219
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.
    Azria D; Ychou M; Jacot W; Thezenas S; Lemanski C; Senesse P; Prost P; Delard R; Masson B; Dubois JB
    Pancreas; 2002 Nov; 25(4):360-5. PubMed ID: 12409830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adenocarcinoma of the pancreas].
    Krulik M
    Presse Med; 1998 Mar; 27(11):531-2. PubMed ID: 9767967
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
    Kunitomo K; Kawahito M; Miura M; Komi N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863
    [No Abstract]   [Full Text] [Related]  

  • 14. Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma.
    Yee NS; Kazi AA; Yee RK
    Curr Clin Pharmacol; 2015; 10(4):256-66. PubMed ID: 26548903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy of unresectable pancreatic carcinoma: a six year experience with 104 patients.
    Whittington R; Dobelbower RR; Mohiuddin M; Rosato FE; Weiss SM
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1639-44. PubMed ID: 6174491
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative chemoradiation therapy for pancreatic cancer.
    Evans DB; Pisters PW
    Surg Clin North Am; 2001 Jun; 81(3):709-13. PubMed ID: 11459284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma.
    Li D; Capanu M; Yu KH; Lowery MA; Kelsen DP; O'Reilly EM
    Clin Colorectal Cancer; 2015 Dec; 14(4):269-76.e1. PubMed ID: 26072442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Lima CMSR
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma.
    Jessup JM; Steele G; Mayer RJ; Posner M; Busse P; Cady B; Stone M; Jenkins R; Osteen R
    Arch Surg; 1993 May; 128(5):559-64. PubMed ID: 8098206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas.
    Haslam JB; Cavanaugh PJ; Stroup SL
    Cancer; 1973 Dec; 32(6):1341-5. PubMed ID: 4127980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.